Voyageur Pharmaceuticals (CVE:VM) Stock Price Up 14.3% – Time to Buy?

Shares of Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) rose 14.3% during mid-day trading on Wednesday . The company traded as high as C$0.08 and last traded at C$0.08. Approximately 1,060,946 shares changed hands during trading, an increase of 981% from the average daily volume of 98,158 shares. The stock had previously closed at C$0.07.

Voyageur Pharmaceuticals Trading Up 50.0 %

The stock has a market cap of C$14.64 million, a P/E ratio of -10.50 and a beta of 0.32. The firm’s fifty day moving average price is C$0.07 and its two-hundred day moving average price is C$0.06. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Further Reading

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.